Chronic Malignancies Working Party (CMWP)
Type d'étude:
Numéro de l'étude:
2005-001628-35
Type de traitement à base de cellules souches:
Maladies:
Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)
Titre court:
MMVAR
Objectif principal:
the hypothesis that treatment with Velcade plus Thalidomide plus Dexamethasone in combination, will result in a longer time progrethe hypothesis that treatment with Velcade plus Thalidomide plus Dexamethasone in combination, will result in a longer time progression than Thalidomide plus Dexamethasone in subjects with relapsed or progressive myeloma after autologous transplanatation.
Principaux critères d'inclusion:
>=18 years old
Pays:
France
Belgique
Allemagne
Suisse
Autriche
Italie
République tchèque
Hongrie
Israël
Royaume Uni
Investigateur principal:
Laurent Garderet
Coordinateur EBMT de l'étude:
Marleen van Os